Mycoplasma Testing Market

Global Mycoplasma Testing Market Report: By Product (Instruments and Kits and Reagents), Technology (PCR, ELISA, Enzymatic Methods, DNA Staining, Other Technologies), and Region (North America, Europe, Asia-Pacific, Latin America, Middle-East and Africa) Global Industry Analysis, Size, Share, Growth, Trends, Regional Analysis, Competitor Analysis and Forecast 2023-2031.

Biotechnology | January 2024 | Report ID: EMR00414 | Pages: 301

Global Mycoplasma Testing market is predicted to reach approximately USD 3.20 billion by 2031, at a CAGR of 13.18% from 2022 to 2031.

The term "mycoplasma testing" describes the process of identifying and getting rid of mycoplasma contamination, which can seriously harm cell cultures and the manufacturing of biopharmaceuticals. The bacteria class Mycoplasma, which does not have a cell wall, is well known for contaminating cell cultures and jeopardising the integrity of scientific and industrial procedures. This contamination may result in subpar products, erroneous research findings, and even threats to patient safety.

The market encompasses a variety of technologies, including Polymerase Chain Reaction (PCR), Enzyme-Linked Immunosorbent Assay (ELISA), enzymatic methods, DNA staining, and other advanced techniques. These technologies play a pivotal role in identifying and mitigating mycoplasma contamination across diverse applications such as cell line testing, bioproduction testing, and various other laboratory procedures. The demand for Mycoplasma Testing is primarily driven by the expanding biopharmaceutical and cell therapy sectors, where maintaining the purity of cell cultures is of paramount importance.

 

 

Global Mycoplasma Testing report scope and segmentation.

Report Attribute

Details

Estimated Market Value (2022)

USD 1.05 billion

Projected Market Value (2031)

USD 3.20 billion

Base Year

2022

Forecast Years

2023 – 2031

Scope of the Report

Historical and Forecast Trends, Industry Drivers and Constraints, Historical and Forecast Market Analysis by Segment- Based on By Product, Technology, Application & Region.

Segments Covered

By Product, Technology, Application & By Region.

Forecast Units

Value (USD Billion or Million), and Volume (Units)

Quantitative Units

Revenue in USD million/billion and CAGR from 2023 to 2031.

Regions Covered

North America, Europe, Asia Pacific, Latin America, and Middle East & Africa.

Countries Covered

U.S., Canada, Mexico, U.K., Germany, France, Italy, Spain, China, India, Japan, South Korea, Brazil, Argentina, GCC Countries, and South Africa, among others.

Report Coverage

Market growth drivers, restraints, opportunities, Porter’s five forces analysis, PEST analysis, value chain analysis, regulatory landscape, market attractiveness analysis by segments and region, company market share analysis.

Delivery Format

Delivered as an attached PDF and Excel through email, according to the purchase option.

 

Global Mycoplasma Testing dynamics

The market for mycoplasma testing is driven by a number of dynamic factors that together influence its growth trajectory. One important factor is the growing use of cell-based therapies and biopharmaceuticals in the biotechnology and pharmaceutical industries. The necessity to guarantee the safety and calibre of bioproducts drives up demand for trustworthy mycoplasma testing solutions at the same time as these industries grow. Extensive regulatory obligations emphasise how crucial thorough mycoplasma testing procedures are in these industries.

Technological advancements play a pivotal role in shaping market dynamics, with continuous innovation in testing methodologies and the development of sophisticated tools for mycoplasma detection. The market is characterized by a competitive landscape, driven by companies striving to introduce cutting-edge solutions that enhance the efficiency and accuracy of mycoplasma testing.

 

Global Mycoplasma Testing drivers

  • Rising Adoption of Biopharmaceuticals and Cell Therapies

One of the main factors propelling the Mycoplasma Testing Market is the growing use of biopharmaceuticals and cell-based therapies in the biotechnology and pharmaceutical industries. As these sectors experience unheard-of growth, it is critical to guarantee the quality and safety of bioproducts. The danger that mycoplasma contamination poses to cell cultures and bioproduction processes has led to a rise in the need for reliable testing solutions. As businesses prioritise efficient mycoplasma testing procedures to preserve the integrity of their products, the market is further propelled by the increase in research and development activities in these sectors.

  • Technological Advancements in Testing Methodologies

Ongoing technological advancements contribute significantly to the market's growth by continually improving testing methodologies for mycoplasma detection. The development of more sensitive, specific, and rapid testing tools enhances the efficiency and accuracy of mycoplasma testing, addressing the evolving challenges in contamination detection. Innovations such as advanced PCR techniques, novel ELISA assays, and cutting-edge enzymatic methods empower researchers and biopharmaceutical manufacturers to detect and eliminate mycoplasma with greater precision. The dynamic nature of technological progress in this field not only meets current industry needs but also anticipates future challenges, driving the adoption of sophisticated mycoplasma testing solutions.

 

Restraints:

  • High Cost of Advanced Testing Technologies

The relatively high cost of advanced mycoplasma testing technologies, like complex PCR and ELISA methods, may prevent their widespread adoption. The cost of purchasing cutting-edge equipment and kits, along with continuous expenditures for consumables and reagents, can put a pressure on the finances of biopharmaceutical companies and smaller research labs. This financial barrier might prevent advanced mycoplasma testing techniques from being widely used, particularly in environments with limited resources.

  • Stringent Regulatory Compliance Requirements

The biotechnology and pharmaceutical industries are subject to strict regulations, which is a constraint on the mycoplasma testing market. Rigid testing procedures and documentation are required to meet and maintain compliance with these regulations, and they can be time- and resource-intensive. Businesses in these industries have to spend a lot of time and money making sure that their mycoplasma testing procedures meet all legal requirements. The adoption of mycoplasma testing solutions may be slowed down by the complexity of these compliance requirements, especially for smaller businesses with weaker regulatory affairs departments.

 

Opportunities:

  • Expansion of Biopharmaceutical and Cell Therapy Sectors in Emerging Markets

The ongoing expansion of the biopharmaceutical and cell therapy sectors in emerging markets presents a significant opportunity for the Mycoplasma Testing Market. As these regions witness increased investment in healthcare infrastructure and research capabilities, there is a growing demand for reliable testing solutions to ensure the safety and quality of bioproducts. Companies that can establish a strong presence in these emerging markets and provide cost-effective yet robust mycoplasma testing solutions stand to benefit from the expanding opportunities in these regions.

 

Segment Overview

  • By Product

Instruments and kits form a critical product segment within the Mycoplasma Testing Market. These comprise an array of instruments and apparatus intended for the identification and examination of mycoplasma contamination. Specialised devices for PCR and ELISA are examples of instruments, whereas kits usually comprise the necessary reagents and consumables to perform mycoplasma testing protocols. The chemical reactions and procedures involved in the detection of mycoplasma DNA or proteins depend heavily on reagents. For mycoplasma testing procedures to be accurate and reliable, the quality of reagents and the instruments and kits working together harmoniously are essential. This section demonstrates the industry's dedication to offering all-inclusive solutions that address the various requirements of biopharmaceutical.

  • By Technology

The technology segment encompasses a diverse array of methodologies employed in mycoplasma testing. Polymerase Chain Reaction (PCR) is a widely used technique for amplifying and detecting mycoplasma DNA, providing high sensitivity and specificity. Enzyme-Linked Immunosorbent Assay (ELISA) involves the detection of mycoplasma antigens or antibodies and is valuable in quantifying contamination levels. Enzymatic methods utilize enzymatic reactions for detection, and DNA staining involves the visualization of mycoplasma DNA through specific dyes. Other technologies may include advanced molecular and genomic approaches designed to enhance the precision and speed of mycoplasma detection. This segment highlights the dynamic nature of mycoplasma testing methodologies, reflecting continuous innovation and adaptation to evolving industry needs.

  • By Application

The application segment defines the diverse contexts in which mycoplasma testing is employed. Cell line testing is a fundamental application, ensuring the integrity and purity of cell cultures, which is critical for reliable research outcomes and bioproduction processes. Bioproduction testing focuses on mycoplasma detection in the production of biopharmaceuticals and cell-based therapies, safeguarding the quality of the final products. Other applications may encompass a range of laboratory procedures where mycoplasma contamination needs to be identified and eliminated. This segment underscores the broad relevance of mycoplasma testing across various scientific and industrial settings, reinforcing its importance in maintaining the quality and safety standards of bioproducts.

 

Global Mycoplasma Testing Overview by Region

North America holds a substantial market share, driven by the presence of a robust biopharmaceutical industry, stringent regulatory standards, and significant investments in research and development. The United States, in particular, is a major contributor to the regional market, owing to the high adoption of advanced mycoplasma testing technologies and a strong emphasis on maintaining product quality and safety.

Europe is closely behind, with major contributors to the market's expansion including France, Germany, and the United Kingdom. The area is well-served by an established biotechnology and pharmaceutical infrastructure as well as proactive regulatory policies that require stringent mycoplasma testing procedures. The biopharmaceutical and cell therapy industries are growing quickly in Asia-Pacific, driven by nations like China, India, and Japan. The region's growing need for advanced testing solutions is a result of rising awareness of the risks of mycoplasma contamination as well as the need for compliance with international regulations.

 

 

Global Mycoplasma Testing market competitive landscape

Major industry participants such as Thermo Fisher Scientific, Merck KGaA, and Lonza Group dominate the market, offering a comprehensive range of instruments, kits, and reagents for mycoplasma testing. These companies focus on strategic initiatives such as mergers, acquisitions, and partnerships to strengthen their product portfolios and expand their global market presence. Additionally, investments in research and development activities aim to introduce technologically advanced solutions, enhancing the accuracy and efficiency of mycoplasma detection.

Emerging players, including Sartorius AG, PromoCell GmbH, and Eurofins Scientific, are gaining traction by introducing innovative technologies and customized solutions to cater to specific industry demands. These companies often emphasize collaborations and partnerships with research institutions and biopharmaceutical manufacturers to foster innovation and gain a competitive edge.

 

Global Mycoplasma Testing Recent Developments

  • Nov 2023, QIAGEN has introduced the latest QIAcuity digital PCR kits and updated software, aiming to broaden their application in the biopharma and food safety sectors. The three newly launched QIAcuity kits are designed to improve digital PCR applications in biopharmaceutical research and food safety, guaranteeing accurate quantification, heightened sensitivity, and cost-effectiveness.

 

Scope of global Mycoplasma Testing report

Global Mycoplasma Testing report segmentation

ATTRIBUTE

DETAILS

By Product

  • Instruments and Kits
  • Reagents

By Technology

  • PCR
  • ELISA
  • Enzymatic Methods
  • DNA Staining
  • Other Technologies

By Application

  • Cell Line Testing
  • Bioproduction Testing
  • Other Applications

By Geography

  • North America (USA, and Canada)
  • Europe (UK, Germany, France, Italy, Spain, Russia and Rest of Europe)
  • Asia Pacific (Japan, China, India, Australia, Southeast Asia and Rest of Asia Pacific)
  • Latin America (Brazil, Mexico, and Rest of Latin America)
  • Middle East & Africa (South Africa, GCC, and Rest of Middle East & Africa)

Customization Scope

  • Available upon request

Pricing

  • Available upon request

 

Objectives of the Study

The objectives of the study are summarized in 5 stages. They are as mentioned below:

  • Global Mycoplasma Testing size and forecast: To identify and estimate the market size for global Mycoplasma Testing market segmented by Product, Technology, Application and by region. Also, to understand the consumption/ demand created by consumers between 2023 and 2031.
  • Market Landscape and Trends: To identify and infer the drivers, restraints, opportunities, and challenges for global Mycoplasma Testing
  • Market Influencing Factors: To find out the factors which are affecting the market of global Mycoplasma Testing among consumers.
  • Company Profiling:  To provide a detailed insight into the major companies operating in the market. The profiling will include the financial health of the company's past 2-3 years with segmental and regional revenue breakup, product offering, recent developments, SWOT analysis, and key strategies.

Research Methodology

Our research methodology has always been the key differentiating reason which sets us apart in comparison from the competing organizations in the industry. Our organization believes in consistency along with quality and establishing a new level with every new report we generate; our methods are acclaimed and the data/information inside the report is coveted. Our research methodology involves a combination of primary and secondary research methods. Data procurement is one of the most extensive stages in our research process. Our organization helps in assisting the clients to find the opportunities by examining the market across the globe coupled with providing economic statistics for each and every region.  The reports generated and published are based on primary & secondary research. In secondary research, we gather data for global Market through white papers, case studies, blogs, reference customers, news, articles, press releases, white papers, and research studies. We also have our paid data applications which includes hoovers, Bloomberg business week, Avention, and others.

Data Collection

Data collection is the process of gathering, measuring, and analyzing accurate and relevant data from a variety of sources to analyze market and forecast trends. Raw market data is obtained on a broad front. Data is continuously extracted and filtered to ensure only validated and authenticated sources are considered. Data is mined from a varied host of sources including secondary and primary sources.

Primary Research

After the secondary research process, we initiate the primary research phase in which we interact with companies operating within the market space. We interact with related industries to understand the factors that can drive or hamper a market. Exhaustive primary interviews are conducted. Various sources from both the supply and demand sides are interviewed to obtain qualitative and quantitative information for a report which includes suppliers, product providers, domain experts, CEOs, vice presidents, marketing & sales directors, Type & innovation directors, and related key executives from various key companies to ensure a holistic and unbiased picture of the market. 

Secondary Research

A secondary research process is conducted to identify and collect information useful for the extensive, technical, market-oriented, and comprehensive study of the market. Secondary sources include published market studies, competitive information, white papers, analyst reports, government agencies, industry and trade associations, media sources, chambers of commerce, newsletters, trade publications, magazines, Bloomberg BusinessWeek, Factiva, D&B, annual reports, company house documents, investor presentations, articles, journals, blogs, and SEC filings of companies, newspapers, and so on. We have assigned weights to these parameters and quantified their market impacts using the weighted average analysis to derive the expected market growth rate.

Top-Down Approach & Bottom-Up Approach

In the top – down approach, the Global Batteries for Solar Energy Storage Market was further divided into various segments on the basis of the percentage share of each segment. This approach helped in arriving at the market size of each segment globally. The segments market size was further broken down in the regional market size of each segment and sub-segments. The sub-segments were further broken down to country level market. The market size arrived using this approach was then crosschecked with the market size arrived by using bottom-up approach.

In the bottom-up approach, we arrived at the country market size by identifying the revenues and market shares of the key market players. The country market sizes then were added up to arrive at regional market size of the decorated apparel, which eventually added up to arrive at global market size.

This is one of the most reliable methods as the information is directly obtained from the key players in the market and is based on the primary interviews from the key opinion leaders associated with the firms considered in the research. Furthermore, the data obtained from the company sources and the primary respondents was validated through secondary sources including government publications and Bloomberg.

Market Analysis & size Estimation

Post the data mining stage, we gather our findings and analyze them, filtering out relevant insights. These are evaluated across research teams and industry experts. All this data is collected and evaluated by our analysts. The key players in the industry or markets are identified through extensive primary and secondary research. All percentage share splits, and breakdowns have been determined using secondary sources and verified through primary sources. The market size, in terms of value and volume, is determined through primary and secondary research processes, and forecasting models including the time series model, econometric model, judgmental forecasting model, the Delphi method, among Flywheel Energy Storage. Gathered information for market analysis, competitive landscape, growth trends, product development, and pricing trends is fed into the model and analyzed simultaneously.

Quality Checking & Final Review

The analysis done by the research team is further reviewed to check for the accuracy of the data provided to ensure the clients’ requirements. This approach provides essential checks and balances which facilitate the production of quality data. This Type of revision was done in two phases for the authenticity of the data and negligible errors in the report. After quality checking, the report is reviewed to look after the presentation, Type and to recheck if all the requirements of the clients were addressed.

Frequently Asked Questions

Global Mycoplasma Testing forecast period is 2023 - 2031.
According to global Mycoplasma Testing research, the market is expected to grow at a CAGR of ~ 13.18% % over the next eight years.
The possible segments in global Mycoplasma Testing are based on by Product, Technology, Application & by region.
The expected market size for Global Mycoplasma Testing is USD 3.20 billion in 2022.
The major players in the market are AECOM, Lennox International Inc., Teledyne Technologies Incorporated, Thermo Fisher Scientific Inc., Abatement Technologies, Waste Connections, Biffa Ltd, Svante Technologies Inc., Carbon Clean Solutions Limited and Veolia Environnement SA.